Monday, August 3, 2020

Savonix-Mitani Sangyo partnership unveils employee early dementia prevention

KUALA LUMPUR, Aug 3 -- Savonix, a global leader in digital cognitive health testing, and Japanese trading company Mitani Sangyo Co Ltd recently announced a strategic partnership to provide Savonix’s digital cognitive assessment to employees over 40.

While the test is not mandatory, it is nevertheless, highly encouraged. Mitani Sangyo also provides benefits to employees with cognitive impairment.

According to a statement, a virtual joint press conference was recently held, with Savonix Chief Executive Officer (CEO) and Founder, Dr Mylea Charvat discussing the collaboration, giving live demonstration and overview of Savonix’s assessment, whereby the importance of dementia prevention was also highlighted.

“Dementia is a health problem facing a super-aging Japanese society, and a risk that will become a huge problem for all Japanese companies that implement long-term employment as they relax or eliminate the retirement age,” said Mitani Sangyo President and CEO, Tadateru Mitani.

“However, it has become clear that dementia can be prevented, and its progress can be stopped by reviewing lifestyle changes and improving social relationships.”

“Savonix is an excellent solution that enables early detection of signs of dementia and provides a preventive action in just 20 minutes. It is a necessary solution not only for us, but also for Japanese companies in this aging country.”

According to Dr Charvat, the partnership with Mitani Sangyo, one of the largest trading companies in Japan, highlights the value Savonix brings to the workplace in terms of employee health and wellness.

-- BERNAMA

No comments:

Post a Comment